Dimensional Fund Advisors LP Ardelyx, Inc. Transaction History

Dimensional Fund Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$6.05 - $9.74 $272,237 - $438,280	-44,998 Reduced 17.51%	211,958 $1.55 Million
Q4 2023 Feb 07, 2024	SELL	$3.29 - $6.64 $38,483 - $77,668	-11,697 Reduced 4.35%	256,956 $1.59 Million
Q3 2023 Nov 09, 2023	SELL	$3.3 - $4.83 $56,921 - $83,312	-17,249 Reduced 6.03%	268,653 $1.1 Million
Q2 2023 Aug 09, 2023	SELL	$3.23 - $4.95 $584 - $895	-181 Reduced 0.06%	285,902 $969,000
Q1 2023 May 12, 2023	SELL	$2.68 - $4.79 $98,149 - $175,424	-36,623 Reduced 11.35%	286,083 $1.37 Million
Q4 2022 Feb 09, 2023	SELL	$1.22 - $2.85 $5,612 - $13,110	-4,600 Reduced 1.41%	322,706 $919,000
Q3 2022 Nov 10, 2022	SELL	$0.59 - $1.44 $7,249 - $17,694	-12,288 Reduced 3.62%	327,306 $389,000
Q1 2022 May 13, 2022	SELL	$0.65 - $1.18 $47,661 - $86,524	-73,326 Reduced 17.76%	339,594 $363,000
Q4 2021 Feb 09, 2022	SELL	$0.86 - $1.7 $160,798 - $317,857	-186,975 Reduced 31.17%	412,920 $454,000
Q3 2021 Nov 12, 2021	SELL	$1.27 - $8.17 $2.16 Million - $13.9 Million	-1,699,826 Reduced 73.91%	599,895 $792,000
Q2 2021 Aug 12, 2021	BUY	$6.55 - $8.98 $1.5 Million - $2.06 Million	229,346 Added 11.08%	2,299,721 $17.4 Million
Q1 2021 May 14, 2021	BUY	$6.1 - $7.69 $1.28 Million - $1.61 Million	209,819 Added 11.28%	2,070,375 $13.7 Million
Q4 2020 Feb 25, 2021	BUY	$5.05 - $7.1 $9.4 Million - $13.2 Million	1,860,556 New	1,860,556 $12 Million

215

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $775M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.